ERBB2 and breast cancer: Tot et al. investigated multifocal and unifocal breast cancer according to the immunophenotype (estrogen and progesterone receptor expression, HER2 overexpression and expression of basal-like markers, CK5/6, CK14, and epidermal growth factor receptor).